You are here

Article info

Article menu

Download PDFPDF

Review
NIR fluorescence imaging and treatment for cancer immunotherapy

Authors

  • Homan Kang Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Min-Woong Kang Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA Department of Thoracic and Cardiovascular Surgery, School of Medicine, Chungnam National University, Daejeon, South Korea PubMed articlesGoogle scholar articles
  • Satoshi Kashiwagi Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Hak Soo Choi Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Hak Soo Choi; hchoi12{at}mgh.harvard.edu; Professor Satoshi Kashiwagi; skashiwagi{at}mgh.harvard.edu
View Full Text

Citation

Kang H, Kang M, Kashiwagi S, et al
NIR fluorescence imaging and treatment for cancer immunotherapy
Journal for ImmunoTherapy of Cancer 2022;10:e004936. doi: 10.1136/jitc-2022-004936

Publication history

  • Accepted June 27, 2022
  • First published July 20, 2022.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.